Medical supplies contracts in Germany

1,508 open tenders

CountryTenderValueClosesDays left

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Liraglutid, ATC A10BJ02 for the period 01.03.2026 - 29.02.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 38439-2026

€11 lot, 2 years

Fri 5 Jan12:00 in Berlin

799days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Potassium iodide, ATC H03CA01, for the period 01.03.2026 - 29.02.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 33270-2026

€11 lot, 2 years

Fri 5 Jan12:00 in Berlin

799days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Budesonide, ATC A07EA06, for the period 01.03.2026 - 29.02.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 34124-2026

€11 lot, 2 years

Fri 5 Jan12:00 in Berlin

799days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active ingredient Betamethasone + Gentamicin, ATC D07CC01 for the period 01.04.26 - 31.03.28 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 111120-2026

€11 lot, 2 years

Mon 5 Feb12:00 in Berlin

830days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Estriol (excluding Dafo. VCR), ATC G03CD01, for the period 01.04.26 – 31.03.28 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 113873-2026

€11 lot, 2 years

Mon 5 Feb12:00 in Berlin

830days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Lercanidipin, ATC C08CA13, for the period 01.04.2026 – 31.03.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 113900-2026

€11 lot, 2 years

Mon 5 Feb12:00 in Berlin

830days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Pyridoxine, ATC M03BX03, for the period 01.04.2026 - 31.03.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 113579-2026

€11 lot, 2 years

Mon 5 Feb12:00 in Berlin

830days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Filgrastim, ATC L03AA02, for the period 01.04.2026 - 31.03.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 112662-2026

€11 lot, 2 years

Mon 5 Feb12:00 in Berlin

830days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Tranylcypromin, ATC N06AF04, for the period 01.04.2026 - 31.03.2028 (plus extension option of 1x12 months)

DAK-Gesundheit, HamburgTED 111445-2026

€11 lot, 2 years

Mon 5 Feb12:00 in Berlin

830days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active ingredient Dexamethasone + Gentamicin, ATC S01CA21 for the period 01.04.2026 - 31.03.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 111258-2026

€11 lot, 2 years

Mon 5 Feb12:00 in Berlin

830days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active ingredient Ipratropium (excluding Dafo. LOV), ATC R03BB01 for the period 01.04.26 - 31.03.28 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 111297-2026

€11 lot, 2 years

Mon 5 Feb12:00 in Berlin

830days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Sultamicillin, ATC J01CR04, for the period 01.04.2026 - 31.03.2028 (plus extension option of 1x12 months)

DAK-Gesundheit, HamburgTED 111816-2026

€11 lot, 2 years

Mon 5 Feb12:00 in Berlin

830days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Caspofungin, ATC J02AX04, for the period 01.04.2026 - 31.03.2028 (plus extension option of 1x12 months)

DAK-Gesundheit, HamburgTED 111473-2026

€11 lot, 2 years

Mon 5 Feb12:00 in Berlin

830days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Levothyroxine, ATC H03AA01, for the period 01.04.2026 - 31.03.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 113048-2026

€11 lot, 2 years

Mon 5 Feb12:00 in Berlin

830days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Methylprednisolone, ATC H02AB04, for the period 01.04.2026 - 31.03.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 112345-2026

€11 lot, 2 years

Mon 5 Feb12:00 in Berlin

830days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Estradiol + Dydrogesteron, ATC G03FA14, for the period 01.04.2026 – 31.03.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 113924-2026

€11 lot, 2 years

Mon 5 Feb12:00 in Berlin

830days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Dexamfetamine, ATC N06BA02, for the period 01.04.2026 - 31.03.2028 (plus extension option of 1x12 months)

DAK-Gesundheit, HamburgTED 111379-2026

€11 lot, 2 years

Mon 5 Feb12:00 in Berlin

830days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance glycerol trinitrate, ATC C05AE01, for the period 01.05.26 – 30.04.28 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 181590-2026

€11 lot, 2 years

Mon 5 Mar12:00 in Berlin

858days

Conclusion of a non-exclusive discount agreement under § 130a, paragraph 8 of the German Social Security Code (SGB V) for the active ingredient Testosterone (excluding DaFo GEL), ATC code G03BA03 for the period from 01.05.26 to 30.04.28 (including V.-option for 1x12 months)

DAK-Gesundheit, HamburgTED 185060-2026

€11 lot, 2 years

Mon 5 Mar12:00 in Berlin

858days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Moxifloxacin, ATC S01AE07 for the period 01.05.26 - 30.04.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 178494-2026

€11 lot, 2 years

Mon 5 Mar12:00 in Berlin

858days

SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.